Therapeutic Vaccine for HIV

NCT01859325 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

NIH

Sponsor class

Conditions

HIV
Therapeutic Vaccine

Interventions

BIOLOGICAL: rVSV
BIOLOGICAL: IL-12 pDNA adjuvant
BIOLOGICAL: HIV-Mag pDNA
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]